Immune-mediated hepatitis with the Moderna vaccine, no longer a coincidence but confirmed

J Hepatol. 2022 Mar;76(3):747-749. doi: 10.1016/j.jhep.2021.09.031. Epub 2021 Oct 5.

Authors

Gloria Shwe Zin Tun¹, Dermot Gleeson², Amer Al-Joudeh², Asha Dube²

Affiliations

¹ Department of Gastroenterology and Hepatology, Sheffield Teaching Hospitals NHS Foundation Trust, Sheffield, United Kingdom. Electronic address: g.tun@nhs.net.
² Department of Gastroenterology and Hepatology, Sheffield Teaching Hospitals NHS Foundation Trust, Sheffield, United Kingdom.

No abstract available

Keywords: Immune-mediated liver damage; autoimmune hepatitis; covid-19; drug induced liver injury.

Publication types

Letter

MeSH terms

2019-nCoV Vaccine mRNA-1273 / adverse effects*
2019-nCoV Vaccine mRNA-1273 / immunology
2019-nCoV Vaccine mRNA-1273 / therapeutic use
Biopsy / methods
COVID-19 / prevention & control
COVID-19 Drug Treatment
Hepatitis, Autoimmune / etiology*
Hepatitis, Autoimmune / pathology
Hepatitis, Autoimmune / physiopathology
Humans
Male
Middle Aged

Substances

2019-nCoV Vaccine mRNA-1273